MC
ENZY

Menta Capital’s Enzymotec Ltd ENZY Stock Holding History

Menta Capital’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-34,314
Closed -$407K – 838
2017
Q4 		$407K Buy
34,314
+8,855
+35% +$103K 0.08% 415
2017
Q3 		$292K Buy
25,459
+5,590
+28% +$55.2K 0.04% 622
2017
Q2 		$161K Sell
19,869
-4,187
-17% -$34.9K 0.02% 721
2017
Q1 		$212K Sell
24,056
-24,973
-51% -$212K 0.02% 747
2016
Q4 		$321K Sell
49,029
-1,469
-3% -$9.67K 0.03% 731
2016
Q3 		$353K Buy
50,498
+2,010
+4% +$16.1K 0.03% 643
2016
Q2 		$405K Buy
48,488
+5,362
+12% +$44.4K 0.06% 580
2016
Q1 		$389K Buy
43,126
+14,295
+50% +$125K 0.05% 602
2015
Q4 		$283K Buy
28,831
+12,961
+82% +$123K 0.04% 671
2015
Q3 		$144K Buy
+15,870
New +$142K 0.02% 658

Menta Capital's ENZY Position: Q1 2018 in Review

Menta Capital sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 34,314 shares — an estimated $407K sold.

Menta Capital first reported a position in ENZY in Q3 2015 and held it in 10 quarters. The position peaked at $407K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Menta Capital reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Menta Capital sold 34,314 Enzymotec Ltd shares in Q1 2018, an estimated $407K.
  • Menta Capital first reported a position in Enzymotec Ltd in Q3 2015 and held it in 10 quarters.
  • Menta Capital's Enzymotec Ltd position peaked at $407K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Menta Capital's 13F filing for Q1 2018, filed 15 May 2018.